SamaCare , a workflow platform for suppliers delivering specialty medicines, introduced it has raised $17 million in an oversubscribed Collection B funding.
New investor Questa Capital led the spherical, with participation from present buyers South Park Commons and Vive Collective.
what it will possibly do
The California-based firm gives a cloud-based workflow automation platform that helps suppliers acquire prior authorization for specialty medication, verify enrollment and confirm advantages. It additionally works with pharmaceutical firms to offer information analytics to assist enhance their remedies.
The corporate will use the funding to increase its script-to-treat operations system, which can leverage synthetic intelligence to carry out administrative duties, create post-prescription workflows, accumulate information insights and improve collaboration amongst supplier workplaces.
Syam Palakurthy, founder and CEO of SamaCare, mentioned: “SamaCare plans to speculate capital to construct a complete script-to-treatment working system to boost the capabilities of our skilled pre-validation platform for sufferers, suppliers and pharmaceutical firms.” cellular well being information in an e mail.
“This implies constructing extra collaborative capabilities, AI-based steerage and information insights into our platform to collectively assist our clients guarantee sufferers overcome administrative and monetary boundaries to beginning therapy.”
market Overview
SamaCare accomplished a $12 million Collection A spherical in 2022.
Different firms providing workflow automation platforms embody Cerner, which In 2021, enterprise software program big Oracle acquired Epic, which supplies scientific and administrative workflow instruments, for $28.3 billion.
